Hemab Therapeutics logo

Hemab Therapeutics Employee Directory

Biotechnology ResearchHovedstaden, Denmark51-200 Employees

Hemab Therapeutics is a clinical-stage biotechnology company focused on preventive therapies for serious, underserved bleeding and thrombotic disorders. It advances monoclonal and bispecific antibody-based candidates designed to prevent bleeding events or thrombotic complications in patients with high unmet medical needs, including conditions such as Glanzmann thrombasthenia, factor VII deficiency, Bernard-Soulier syndrome, and von Willebrand disease. The company operates from Cambridge, Massachusetts and Copenhagen, Denmark, and has outlined a plan to advance five clinical assets by 2025 under its Hemab 1-2-5 strategy. This positions Hemab within the biotechnology research sector as a developer focused on prophylactic biologics for rare clotting disorders. In 2025, Hemab appointed Anant Murthy as Chief Operating Officer, reflecting organizational growth alongside its clinical development efforts.

Find Hemab Therapeutics employees' phone numbers or email addresses

Hemab Therapeutics Global Highlights

Location
Employees

Europe
51

Minus sign iconPlus sign icon
  • Denmark
    41
  • Sweden
    3
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • Austria
    1
  • France
    1
  • Poland
    1
  • Italy
    1
  • Switzerland
    1

North America
37

Minus sign iconPlus sign icon
  • United States Of America
    36
  • Canada
    1

Asia
1

Minus sign iconPlus sign icon
  • United Arab Emirates
    1

Hemab Therapeutics's Leadership

  • Stylized image of a person
    M. B.
    Chief Financial Officer
    Phone icon
  • Stylized image of a person
    K. K. J.
    Vice President Finance
    Phone icon
  • Stylized image of a person
    A. R. H. S.
    Vice President Drug Product Development
    Phone icon
  • Stylized image of a person
    E. B.
    Vice President Regulatory Affairs
    Phone icon
  • Stylized image of a person
    H. Ø.
    Scientific Vice President
    Phone icon
  • Stylized image of a person
    C. B.
    Svp, Cmc And Manufacturing
    Phone icon
  • Stylized image of a person
    T. B.
    Vp, Research
    Phone icon
  • Stylized image of a person
    C. E. R.
    Vice President, Nonclinical Development
    Phone icon

Hemab Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Entrepreneurship
  • Sales
  • Human Resources
  • Other
  • Legal

Contact profiles from Hemab Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    P. J.
    Director Cmc Dp Development
    Phone icon
    Denmark
    Jun 27, 2026

Frequently Asked Questions

What is Hemab Therapeutics known for?

Minus sign iconPlus sign icon
Hemab Therapeutics was founded in 2020 operates in the Biotechnology Research industry. Explore Hemab Therapeutics's company overview page for more information.

What is Hemab Therapeutics's most common email format?

Minus sign iconPlus sign icon
Hemab Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Hemab Therapeutics email formats with LeadIQ.

How many employees does Hemab Therapeutics have currently?

Minus sign iconPlus sign icon
Hemab Therapeutics has approximately 91 employees as of July 2026. These team members are located across 3 continents, including EuropeNorth AmericaAsia.

Who are Hemab Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Hemab Therapeutics's key employees include:

  • Chief Financial Officer: M. B.
  • Vice President Finance: K. K. J.
  • Vice President Drug Product Development: A. R. H. S.
  • Vice President Regulatory Affairs: E. B.
  • Scientific Vice President: H. Ø.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.